Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puja Gupta

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Hematology & Oncology|May 10, 2013
Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing gliomaChan-Juan Shen, Yu-Xiu Yang, Ethan Q Han, et al.
Science Translational Medicine|June 17, 2021
Enhancing proteasomal processing improves survival for a peptide vaccine used to treat glioblastomaMario Fidanza, Puja Gupta, Anin Sayana, et al.
Cancer Research|December 25, 2013
Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant IIIDavid R Emlet, Puja Gupta, Marina Holgado-Madruga, et al.
International Immunopharmacology|June 13, 2023
Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effectSaurabh Kumar Gupta, Dievya Gohil, Deepshikha Dutta, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Hematology & Oncology|May 10, 2013
Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing gliomaChan-Juan Shen, Yu-Xiu Yang, Ethan Q Han, et al.
Science Translational Medicine|June 17, 2021
Enhancing proteasomal processing improves survival for a peptide vaccine used to treat glioblastomaMario Fidanza, Puja Gupta, Anin Sayana, et al.
Cancer Research|December 25, 2013
Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant IIIDavid R Emlet, Puja Gupta, Marina Holgado-Madruga, et al.
International Immunopharmacology|June 13, 2023
Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effectSaurabh Kumar Gupta, Dievya Gohil, Deepshikha Dutta, et al.
Pageof 3